Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Tuberculosis Is Back on the Rise: What To Know About Symptoms and Treatment
TUEDSAY, July 16, 2025 Tuberculosis (TB) was the leading cause of death in the United States in the 19th and 20th centuries. By 1900, TB which usually attacks t
Doctors Overlooking Common Cause Of High Blood Pressure, New Guidelines Say
WEDNESDAY, July 16, 2025 Doctors are regularly overlooking a common hormone-driven cause of high blood pressure, a new paper warns. As many as 30 of high blood
AI Can Help Screen For Vision-Destroying Diabetic Eye Disease
WEDNESDAY, July 16, 2025 A new AI-powered retina tracker can help doctors screen for a vision-destroying diabetic eye disease, researchers say.The Simple Mobile
Loneliness Of Widowhood Isn't Diminished By Presence Of Adult Children, Study Says
WEDNESDAY, July 16, 2025 Adult children aren t likely to fill the void left by the loss of a spouse, a new study says.Becoming widowed might cause a stronger bo
Baxdrostat Met the Primary and All Secondary Endpoints in BaxHTN Phase III Trial in Patients with Uncontrolled or Treatment Resistant Hypertension
Positive high-level results from the BaxHTN Phase III trial showed baxdrostat at two doses (2mg and 1mg) demonstrated a statistically significant and clinically
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill MK-8527
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally Merck (NYSE MRK), known as MSD outsi
Shorla Oncology Announces FDA Orphan Drug Designation for SH-110 to Treat Rare Brain Cancer Using Oral Liquid
Shorla Oncology ( Shorla ), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan
Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA
Adagene Inc. ( Adagene or the Company ) (Nasdaq ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced o
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions